Fereidoon Daryaee

608 total citations
18 papers, 463 citations indexed

About

Fereidoon Daryaee is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Fereidoon Daryaee has authored 18 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Organic Chemistry. Recurrent topics in Fereidoon Daryaee's work include Antibiotic Resistance in Bacteria (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Computational Drug Discovery Methods (3 papers). Fereidoon Daryaee is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Computational Drug Discovery Methods (3 papers). Fereidoon Daryaee collaborates with scholars based in United States, Germany and Norway. Fereidoon Daryaee's co-authors include Peter J. Tonge, Stephen G. Walker, Stewart L. Fisher, Zhuo Zhang, Andrew Chang, Peter Smith‐Jones, Michael Hale, John C. O’Donnell, Kerry E. Murphy-Benenato and Alvaro A. Ordoñez and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Biochemistry.

In The Last Decade

Fereidoon Daryaee

18 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fereidoon Daryaee United States 12 227 94 77 77 65 18 463
Sameh H. Soror Egypt 15 408 1.8× 88 0.9× 36 0.5× 102 1.3× 24 0.4× 36 650
Catherine Piveteau France 12 220 1.0× 94 1.0× 44 0.6× 21 0.3× 37 0.6× 25 496
Behzad Jafari Iran 12 232 1.0× 147 1.6× 43 0.6× 68 0.9× 13 0.2× 42 572
Opeyemi Soremekun South Africa 14 178 0.8× 50 0.5× 59 0.8× 16 0.2× 15 0.2× 61 468
Michael Hale United States 13 329 1.4× 240 2.6× 75 1.0× 24 0.3× 14 0.2× 18 650
Daniel Conole United Kingdom 17 498 2.2× 151 1.6× 43 0.6× 15 0.2× 36 0.6× 34 752
Mutaib M. Mashraqi Saudi Arabia 12 184 0.8× 80 0.9× 90 1.2× 16 0.2× 11 0.2× 36 364
Divita Garg Germany 11 427 1.9× 130 1.4× 57 0.7× 48 0.6× 10 0.2× 19 591
Jan S. Kramer Germany 13 211 0.9× 118 1.3× 51 0.7× 9 0.1× 33 0.5× 32 530
Muhammad Hassan Pakistan 8 167 0.7× 42 0.4× 69 0.9× 39 0.5× 13 0.2× 16 318

Countries citing papers authored by Fereidoon Daryaee

Since Specialization
Citations

This map shows the geographic impact of Fereidoon Daryaee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fereidoon Daryaee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fereidoon Daryaee more than expected).

Fields of papers citing papers by Fereidoon Daryaee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fereidoon Daryaee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fereidoon Daryaee. The network helps show where Fereidoon Daryaee may publish in the future.

Co-authorship network of co-authors of Fereidoon Daryaee

This figure shows the co-authorship network connecting the top 25 collaborators of Fereidoon Daryaee. A scholar is included among the top collaborators of Fereidoon Daryaee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fereidoon Daryaee. Fereidoon Daryaee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Li, Y, Fereidoon Daryaee, Patricia Alfonso, et al.. (2023). Discovery of Novel Bruton’s Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy. Journal of Medicinal Chemistry. 66(11). 7454–7474. 9 indexed citations
2.
Daryaee, Fereidoon, et al.. (2023). Evaluating the Impact of the Tyr158 pKa on the Mechanism and Inhibition of InhA, the Enoyl-ACP Reductase from Mycobacterium tuberculosis. Biochemistry. 62(12). 1943–1952. 8 indexed citations
3.
Li, Yong, Fereidoon Daryaee, S.L. Delker, et al.. (2022). Structure–Kinetic Relationship Studies for the Development of Long Residence Time LpxC Inhibitors. Journal of Medicinal Chemistry. 65(17). 11854–11875. 14 indexed citations
4.
Wang, Nan, et al.. (2021). Impact of Target Turnover on the Translation of Drug-Target Residence Time to Time-Dependent Antibacterial Activity. ACS Infectious Diseases. 7(9). 2755–2763. 8 indexed citations
5.
Daryaee, Fereidoon, et al.. (2020). Correlating Drug–Target Residence Time and Post-antibiotic Effect: Insight into Target Vulnerability. ACS Infectious Diseases. 6(4). 629–636. 22 indexed citations
6.
Li, Yong, Fereidoon Daryaee, Do Young Noh, et al.. (2020). Positron Emission Tomography Imaging of Staphylococcus aureus Infection Using a Nitro-Prodrug Analogue of 2-[18F]F-p-Aminobenzoic Acid. ACS Infectious Diseases. 6(8). 2249–2259. 16 indexed citations
7.
Daryaee, Fereidoon & Peter J. Tonge. (2019). Pharmacokinetic–pharmacodynamic models that incorporate drug–target binding kinetics. Current Opinion in Chemical Biology. 50. 120–127. 35 indexed citations
8.
Zhang, Zhuo, Alvaro A. Ordoñez, Hui Wang, et al.. (2018). Positron Emission Tomography Imaging with 2-[18F]F-p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug Response. ACS Infectious Diseases. 4(11). 1635–1644. 63 indexed citations
9.
Zhang, Zhuo, Alvaro A. Ordoñez, Peter Smith‐Jones, et al.. (2017). The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography. PLoS ONE. 12(2). e0170871–e0170871. 16 indexed citations
10.
Cummings, Jason E., Fereidoon Daryaee, Gopal R. Bommineni, et al.. (2017). Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase. Biochemistry. 56(13). 1865–1878. 5 indexed citations
11.
Daryaee, Fereidoon, et al.. (2017). A quantitative mechanistic PK/PD model directly connects Btk target engagement and in vivo efficacy. Chemical Science. 8(5). 3434–3443. 27 indexed citations
12.
Yu, Weixuan, Fereidoon Daryaee, Susan E. Knudson, et al.. (2017). Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors. Journal of the American Chemical Society. 139(9). 3417–3429. 46 indexed citations
13.
Daryaee, Fereidoon, et al.. (2016). A Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA That Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway. ACS Infectious Diseases. 2(5). 329–340. 26 indexed citations
14.
Daryaee, Fereidoon, Andrew Chang, J. Schiebel, et al.. (2016). Correlating drug–target kinetics and in vivo pharmacodynamics: long residence time inhibitors of the FabI enoyl-ACP reductase. Chemical Science. 7(9). 5945–5954. 24 indexed citations
15.
Lai, Cheng‐Tsung, Jochen Kuper, Junjie Zou, et al.. (2016). Selectivity of Pyridone- and Diphenyl Ether-Based Inhibitors for the Yersinia pestis FabV Enoyl-ACP Reductase. Biochemistry. 55(21). 2992–3006. 8 indexed citations
16.
Walkup, Grant K., Philip L. Ross, Fereidoon Daryaee, et al.. (2015). Translating slow-binding inhibition kinetics into cellular and in vivo effects. Nature Chemical Biology. 11(6). 416–423. 116 indexed citations
17.
Kobarfard, Farzad, Vanessa Yardley, Susan Little, Fereidoon Daryaee, & Kelly Chibale. (2011). Synthesis of Aminoquinoline‐Based Aminoalcohols and Oxazolidinones and Their Antiplasmodial Activity. Chemical Biology & Drug Design. 79(3). 326–331. 9 indexed citations
18.
Daryaee, Fereidoon, Farzad Kobarfard, Ali Khalaj, & Parissa Farnia. (2008). Synthesis and evaluation of in vitro anti-tuberculosis activity of N-substituted glycolamides. European Journal of Medicinal Chemistry. 44(1). 289–295. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sameh H. Soror Breakdown of academic impact, for papers by Catherine Piveteau Breakdown of academic impact, for papers by Behzad Jafari Breakdown of academic impact, for papers by Opeyemi Soremekun Breakdown of academic impact, for papers by Michael Hale Breakdown of academic impact, for papers by Daniel Conole Breakdown of academic impact, for papers by Mutaib M. Mashraqi Breakdown of academic impact, for papers by Divita Garg Breakdown of academic impact, for papers by Jan S. Kramer Breakdown of academic impact, for papers by Muhammad Hassan
Rankless by CCL
2026